Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05379725 · ClinicalTrials.gov registry record · NA
Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05379725: Clinical Trial NA study, sponsored by University of Florida.
NCT05379725 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05379725, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a 4-month randomized controlled trial to evaluate the feasibility of 'good and very good' adherence to the Mediterranean dietary pattern and to a high-fermented-food diet by individuals with Systemic lupus erythematosus (SLE).
Primary Outcome
Percent of participants achieving 'good to very good adherence') as assessed by the 14-day Mediterranean diet questionnaire (MEDAS) score
Interventions
- OTHER Mediterranean Dietary Pattern
- OTHER High Fermented Food Dietary Pattern
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2025-03-01 |
| Phase | NA |
Why NCT05379725 stopped before completion
NCT05379725 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Mediterranean Dietary Pattern is the first listed.
NCT05379725 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05379725 about?
NCT05379725 is a clinical study titled "Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus". This is a 4-month randomized controlled trial to evaluate the feasibility of 'good and very good' adherence to the Mediterranean dietary pattern and to a high-fermented-food diet by individuals with Systemic lupus erythematosus (SLE).
What is the current status of trial NCT05379725?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2022-03-22. Estimated completion is 2025-03-01.
What interventions are being tested in trial NCT05379725?
The interventions under investigation include: Mediterranean Dietary Pattern (OTHER), High Fermented Food Dietary Pattern (OTHER).
Who is sponsoring clinical trial NCT05379725?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05379725's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI